Nimbus founding CSO Rosana Kapeller leaves to explore exec role; AI startup BioXcel pockets $60M from IPO
→ Having helped turn “the vision of computational-based drug discovery into reality” at Nimbus Therapeutics, founding CSO Rosana Kapeller has decided it …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
